Aier Eye Hospital Group Co., Ltd.
SZSE:300015.SZ
17.54 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 20,367.157 | 16,109.947 | 15,000.809 | 11,912.41 | 9,990.104 | 8,008.574 | 5,962.846 | 4,000.402 | 3,165.58 | 2,402.048 | 1,984.967 | 1,640.13 | 1,310.624 | 864.877 | 606.45 | 439.121 | 314.904 | 191.189 |
| Cost of Revenue
| 10,021.975 | 7,980.389 | 7,211.887 | 5,833.826 | 5,064.553 | 4,244.808 | 3,203.073 | 2,155.809 | 1,690.659 | 1,323.206 | 1,073.976 | 902.5 | 585.427 | 377.343 | 260.203 | 195.722 | 137.797 | 92.466 |
| Gross Profit
| 10,345.182 | 8,129.558 | 7,788.922 | 6,078.584 | 4,925.551 | 3,763.766 | 2,759.772 | 1,844.593 | 1,474.921 | 1,078.842 | 910.992 | 737.631 | 725.197 | 487.534 | 346.247 | 243.399 | 177.107 | 98.723 |
| Gross Profit Ratio
| 0.508 | 0.505 | 0.519 | 0.51 | 0.493 | 0.47 | 0.463 | 0.461 | 0.466 | 0.449 | 0.459 | 0.45 | 0.553 | 0.564 | 0.571 | 0.554 | 0.562 | 0.516 |
| Reseach & Development Expenses
| 333.489 | 271.719 | 222.55 | 164.248 | 152.312 | 97.495 | 30.594 | 21.915 | 18.1 | 9.58 | 4.102 | 3.092 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 636.944 | 499.222 | 442.095 | 365.935 | 392.59 | 325.958 | 275.655 | 198.209 | 143.146 | 122.439 | 117.114 | 95.324 | 84.409 | 53.364 | 136.478 | 102.155 | 84.082 | 53.997 |
| Selling & Marketing Expenses
| 1,966.31 | 1,555.631 | 1,446.861 | 1,066.462 | 1,048.543 | 825.548 | 774.032 | 512.239 | 404.909 | 272.782 | 229.196 | 197.804 | 161.291 | 104.243 | 72.445 | 45.928 | 28.503 | 16.54 |
| SG&A
| 2,603.255 | 2,054.853 | 1,888.957 | 1,432.397 | 1,441.133 | 1,151.506 | 1,049.687 | 710.448 | 548.055 | 395.221 | 346.31 | 293.129 | 245.7 | 157.607 | 208.923 | 148.083 | 112.584 | 70.537 |
| Other Expenses
| -396.928 | 1,782.304 | 1,452.789 | 1,040.138 | 910.802 | -215.951 | -84.167 | -13.728 | -48.42 | -21.196 | -15.141 | -5.442 | -1.709 | 7.7 | 5.568 | 0.544 | -0.234 | 1.381 |
| Operating Expenses
| 4,796.6 | 4,108.877 | 3,564.296 | 2,636.783 | 2,504.247 | 1,984.223 | 1,603.223 | 1,146.039 | 874.33 | 656.7 | 578.833 | 483.569 | 488.134 | 321.235 | 217.34 | 163.948 | 124.184 | 75.886 |
| Operating Income
| 4,947.947 | 3,534.5 | 3,493.998 | 2,674.177 | 2,021.843 | 1,557.738 | 1,111.262 | 700.502 | 600.671 | 429.351 | 320.415 | 252.405 | 242.274 | 170.973 | 123.409 | 72.514 | 49.336 | 17.893 |
| Operating Income Ratio
| 0.243 | 0.219 | 0.233 | 0.224 | 0.202 | 0.195 | 0.186 | 0.175 | 0.19 | 0.179 | 0.161 | 0.154 | 0.185 | 0.198 | 0.203 | 0.165 | 0.157 | 0.094 |
| Total Other Income Expenses Net
| -396.928 | -199.444 | -346.243 | -310.902 | -181.602 | -399.328 | -129.454 | -14.337 | -50.423 | -15.055 | -27.259 | -7.649 | 2.799 | 12.374 | -4.592 | -6.439 | -5.054 | -3.667 |
| Income Before Tax
| 4,551.019 | 3,335.056 | 3,147.755 | 2,363.274 | 1,840.241 | 1,380.215 | 1,027.095 | 684.217 | 550.167 | 407.087 | 304.899 | 246.413 | 239.862 | 178.673 | 124.315 | 73.012 | 47.869 | 19.17 |
| Income Before Tax Ratio
| 0.223 | 0.207 | 0.21 | 0.198 | 0.184 | 0.172 | 0.172 | 0.171 | 0.174 | 0.169 | 0.154 | 0.15 | 0.183 | 0.207 | 0.205 | 0.166 | 0.152 | 0.1 |
| Income Tax Expense
| 895.023 | 646.059 | 677.852 | 486.105 | 409.082 | 314.366 | 234.334 | 117.106 | 113.586 | 94.203 | 85.583 | 64.341 | 68.169 | 54.511 | 34.401 | 13.335 | 12.045 | 5.915 |
| Net Income
| 3,358.872 | 2,524.231 | 2,323.344 | 1,723.805 | 1,378.921 | 1,008.937 | 742.515 | 557.467 | 428.044 | 309.186 | 223.496 | 182.547 | 171.928 | 120.31 | 92.489 | 61.367 | 38.98 | 14.592 |
| Net Income Ratio
| 0.165 | 0.157 | 0.155 | 0.145 | 0.138 | 0.126 | 0.125 | 0.139 | 0.135 | 0.129 | 0.113 | 0.111 | 0.131 | 0.139 | 0.153 | 0.14 | 0.124 | 0.076 |
| EPS
| 0.36 | 0.27 | 0.26 | 0.19 | 0.16 | 0.15 | 0.11 | 0.086 | 0.069 | 0.05 | 0.036 | 0.03 | 0.028 | 0.019 | 0.019 | 0.013 | 0.009 | 0.004 |
| EPS Diluted
| 0.36 | 0.27 | 0.26 | 0.19 | 0.16 | 0.15 | 0.11 | 0.086 | 0.067 | 0.05 | 0.036 | 0.03 | 0.028 | 0.019 | 0.019 | 0.013 | 0.009 | 0.004 |
| EBITDA
| 6,666.572 | 5,204.877 | 5,065.767 | 3,680.279 | 2,671.673 | 1,882.441 | 1,294.738 | 848.151 | 739.52 | 536.929 | 433.616 | 353.142 | 326.28 | 241.28 | 170.954 | 118.334 | 94.835 | 47.169 |
| EBITDA Ratio
| 0.327 | 0.323 | 0.338 | 0.309 | 0.267 | 0.235 | 0.217 | 0.212 | 0.234 | 0.224 | 0.218 | 0.215 | 0.249 | 0.279 | 0.282 | 0.269 | 0.301 | 0.247 |